MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe : vimarsana.com

NexoBrid complements PMI’s portfolio, allowing it to provide a comprehensive solution for burn patientsYAVNE, Israel, and DENKENDORF, Germany, Nov. 08, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, and PolyMedics Innovations (PMI), an innovative biomaterials company specializing in effective wounds treatment, today announced an agreement for the promotion of NexoBrid® in Ge

Related Keywords

United States , Luxembourg , Israel , Japan , Austria , Germany , Denkendorf , Baden Wüberg , Switzerland , Belgium , Yavne , Hamerkaz , Netherlands , Luxemburg , Hani Luxenburg , Christian Planck , Alicia Torrenova , Development Of Nexobrid , Development Authority , Linkedin , Lifesci Advisors , European Union , German Mittelstand Company , Mediwound Ltd , Exchange Commission , European Medicines Agency , Us Biomedical Advanced Research , Nasdaq , Polymedics Innovations , Vice President , Advanced Research , Medics Innovations , Quarterly Reports , Wound Contacts , Sci Advisors , Mediwound Ltd , Iopharmaceutical Company , Dwd , Issue Repair , Ermany , Ach , Ustomer Access ,